Dr. Daniel Deschler has spent more than two decades dedicated to improving cancer care and reconstruction. He received his medical degree from Harvard Medical School prior to completing his residency in otolaryngology–head and neck surgery from the University of California, San Francisco. He then completed an advanced fellowship in head and neck surgical oncology and microvascular reconstruction with Dr. Richard Hayden at Hahnemann University Hospital. Dr. Deschler returned to Boston in 2000 to join the staff at Mass. Eye and Ear and now serves as the Vice Chair of Academic Affairs in the Department of Otolaryngology at Mass. Eye and Ear and a Professor of Otolaryngology at Harvard Medical School.
Dr. Deschler has authored more than 180 peer-reviewed publications, as well as numerous book chapters and education reviews. He serves on the editorial board of several publications, is an Associate Editor for Otolaryngology—Head and Neck Surgery, and is a reviewer for 35 journals. He has served as Chairman of the Head and Neck Surgery Committee of the American Academy of Otolaryngology—Head and Neck Surgery for the last several years and is a former President of the Society of University Otolaryngologist—Head and Neck Surgeons.
Dr. Deschler’s clinical interests cover the breadth of head and neck oncologic and reconstructive surgery including, advanced malignancies of the upper aerodigestive tract, salivary gland diseases, microvascular reconstruction, and general head and neck reconstruction.
His research interests include investigations into the prevention of thrombosis in microvascular surgery, speech following pharyngeal reconstruction, and management issues in the treatment of advanced head and neck malignancies.
Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment. Nardi V, Sadow PM, Juric D, Zhao D, Cosper AK, Bergethon K, Scialabba VL, Batten JM, Borger DR, Iafrate AJ, Heist RS, Lawrence DP, Flaherty KT, Bendell JC, Deschler DG, Li Y, Wirth LJ, Dias-Santagata D. Clin Cancer Res. 2012 Nov 27.
Pathology quiz case 3. Carcinoma ex pleomorphic adenoma(CXPA), salivary duct carcinoma type, noninvasive. Naunheim MR, Abbott MM, Lin HW, Faquin WC, Deschler DG. Arch Otolaryngol Head Neck Surg. 2012 Aug 1;138(8):781.
Survival differences among American Indians/Alaska natives with head and neck squamous cell carcinoma. Dwojak SM, Sequist TD, Emerick K, Deschler DG. Head Neck. 2012 Aug 8.
Free flap reconstruction in 1999 and 2009: Changing case characteristics and outcomes. Kakarala K, Emerick KS, Lin DT, Rocco JW, Deschler DG. Laryngoscope. 2012 Oct;122(10):2160–3.
Risk of incisional recurrence after midface and anterior skull base surgery in sinonasal malignancies. Moore MG, Lin DT, Deschler DG, Wang JJ, Chan AW. Skull Base. 2011 Mar;21(2):87–92.
Risk of sinonasal-cutaneous fistula after treatment for advanced sinonasal cancer. Cianchetti M, Varvares MA, Deschler DG, Liebsch NJ, Wang JJ, Chan AW. J Surg Oncol. 2012 Mar;105(3):261–5.
Temporal bone giant cell tumour: Report of a second primary giant cell tumour of the temporal bone and infratemporal fossa. Roberts DS, Faquin WC, Deschler DG. B-ENT. 2011;7(4):301–3.
Serial suture ligation glossectomy for squamous cell carcinoma in the setting of a massive lymphovascular malformation. Chien W, Lin HW, Deschler DG. Head Neck. 2012 Feb 6.
Re-animation and rehabilitation of the paralyzed face in head and neck cancer patients. Divi V, Deschler DG. Clin Anat. 2012 Jan;25(1):99–107.
Effect of glossectomy technique on histopathologic assessment in a rat model. Kakarala K, Faquin WC, Deschler DG. Head Neck. 2011 Nov;33(11):1576–80.
View a complete list of publications on pubmed.gov »